257 related articles for article (PubMed ID: 11898580)
41. Transient ischemic attacks: Part II. Treatment.
Solenski NJ
Am Fam Physician; 2004 Apr; 69(7):1681-8. PubMed ID: 15086040
[TBL] [Abstract][Full Text] [Related]
42. [Antiplatelet treatment for secondary prevention of ischemic stroke or transient ischemic attack].
Barinagarrementeria F; Arauz A; Ruiz-Sandoval JL; Cantú C; Leyva A; Murillo L; Villarreal J; Vargas RD; Alegría MA; Merino JG; Romano J;
Rev Invest Clin; 2010; 62(2):135-40. PubMed ID: 20597393
[No Abstract] [Full Text] [Related]
43. 2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack.
Wang Y; Liu M; Pu C
Int J Stroke; 2017 Apr; 12(3):302-320. PubMed ID: 28381199
[TBL] [Abstract][Full Text] [Related]
44. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2006 Apr; (2):CD001820. PubMed ID: 16625549
[TBL] [Abstract][Full Text] [Related]
45. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
Sztriha LK; Vécsei L
Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
[TBL] [Abstract][Full Text] [Related]
46. Patients enrolled in large randomized clinical trials of antiplatelet treatment for prevention after transient ischemic attack or ischemic stroke are not representative of patients in clinical practice: the Netherlands Stroke Survey.
Maasland L; van Oostenbrugge RJ; Franke CF; Scholte Op Reimer WJ; Koudstaal PJ; Dippel DW;
Stroke; 2009 Aug; 40(8):2662-8. PubMed ID: 19556533
[TBL] [Abstract][Full Text] [Related]
47. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
48. Progress in clinical neurosciences: pharmacotherapies for the secondary prevention of stroke.
Hackam DG; Kapral MK
Can J Neurol Sci; 2004 Aug; 31(3):295-303. PubMed ID: 15376471
[TBL] [Abstract][Full Text] [Related]
49. Preventing recurrent cerebrovascular events in patients with stroke or transient ischemic attack: the current data.
Bergman D
J Am Acad Nurse Pract; 2011 Dec; 23(12):659-66. PubMed ID: 22145656
[TBL] [Abstract][Full Text] [Related]
50. [Antithrombotic therapy in patients with first-ever stroke and known non-rheumatic atrial fibrillation].
Gandjour J; Zeindler J; Georgiadis D; Baumgartner RW
Praxis (Bern 1994); 2005 Jan; 94(4):97-104. PubMed ID: 15732803
[TBL] [Abstract][Full Text] [Related]
51. Drug treatments in the secondary prevention of ischaemic stroke.
Schulz UG
Maturitas; 2013 Nov; 76(3):267-71. PubMed ID: 23769546
[TBL] [Abstract][Full Text] [Related]
52. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischemic attack or minor stroke of presumed arterial origin.
Algra A; De Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
Stroke; 2003 Jan; 34(1):234-5. PubMed ID: 12511782
[No Abstract] [Full Text] [Related]
53. New insights in antiplatelet therapy for patients with ischemic stroke.
Chaturvedi S; Bhattacharya P
Neurologist; 2011 Sep; 17(5):255-62. PubMed ID: 21881467
[TBL] [Abstract][Full Text] [Related]
54. Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.
Wang Y; Chen W; Wang Y
Curr Cardiol Rep; 2015 Oct; 17(10):89. PubMed ID: 26294261
[TBL] [Abstract][Full Text] [Related]
55. Evolving landscape of stroke prevention in atrial fibrillation within the UK between 2012 and 2016: a cross-sectional analysis study using CPRD.
Lacoin L; Lumley M; Ridha E; Pereira M; McDonald L; Ramagopalan S; Lefèvre C; Evans D; Halcox JP
BMJ Open; 2017 Sep; 7(9):e015363. PubMed ID: 28951401
[TBL] [Abstract][Full Text] [Related]
56. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2007 Jul; (3):CD001820. PubMed ID: 17636684
[TBL] [Abstract][Full Text] [Related]
57. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici MG; Mattle HP; Rothwell PM;
Cerebrovasc Dis; 2009; 27(5):509-18. PubMed ID: 19372653
[TBL] [Abstract][Full Text] [Related]
58. Secondary prevention of ischemic stroke.
Rantanen K; Tatlisumak T
Curr Drug Targets; 2004 Jul; 5(5):457-72. PubMed ID: 15216912
[TBL] [Abstract][Full Text] [Related]
59. Antithrombotic medication for stroke prevention.
Weimar C; Weber R; Diener HC
Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1245-54. PubMed ID: 19814667
[TBL] [Abstract][Full Text] [Related]
60. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
